近日，德国权威第三方安全评测机构 AV-TEST 发布最新高级威胁防护（ ATP ）测试结果，华为 HiSec Endpoint 智能终端安全系统凭借其卓越的防护能力，以满分成绩通过全部 10 项核心测试。这一成绩不仅印证了 HiSec Endpoint 在高级威胁检测领域的技术领先性，也为政府、企业等关键场景提供了可靠的终端安全解决方案。在当前的网络安全形势下，终端安全防护的重要性日益凸显， ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Endpoints must become more intelligent, ...

MSK played a central role in the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC)’s landmark decision in April 2024 to accept measurable residual disease (MRD) as an ...

Q3 2025 Management View CEO Frank Bedu-Addo provided an update on advancing PDS0101 (Versamune HPV) in HPV16-positive recurrent and/or metastatic head and neck cancer, highlighting the completion of ...

Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction ...

The rapid pace of digital transformation has increased operational efficiency and enhanced the customer experience – but it has also created a nightmare for CISOs. From mobile devices scattered across ...

Two of Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) candidates have failed to reach their primary endpoint in a ...

(RTTNews) - Avalo Therapeutics, Inc. (AVTX) reported topline results from the Phase 2 placebo-controlled trial evaluating AVTX-002 in patients with poorly controlled non-eosinophilic asthma. The trial ...

Novartis (NVS) (OTCPK:NVSEF) has announced that its next-generation malaria treatment, KLU156 (GanLum), developed with Swiss ...

Trodelvy did not meet the primary endpoint of progression-free survival in the ASCENT-07 trial for HR-positive, HER2-negative ...